Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
Sunday 21 April 2019 2:07 pm  |  Updated:  Monday 03 June 2019 12:51 am

US owner of healthcare firm The Priory Group eyes £1bn sale amid scandal over quality of care

By: James Warrington

Add as a preferred source on Google

The US healthcare firm behind The Priory Group is mulling a £1bn sale of the mental healthcare provider amid a scandal over the quality of care in its hospitals.

Acadia Healthcare has appointed a financial adviser to explore a possible sale of the firm, the Mail on Sunday reported, citing City sources.

Read more: Only a failing health system would discourage patients from getting tested

The Priory Group operates over 450 private and NHS facilities treating people with addiction and mental health problems. Its clinic in Roehampton is famous for treating celebrities including Kate Moss, Robbie Williams and Paul Gascoigne.

But the company, which holds roughly £720m in government contracts, has been hit by a string of recent scandals over the quality of care at its institutions.

Earlier this month The Priory Group was handed down a £300,000 fine over the death of a 14-year-old girl who was found hanged while in the care of a Priory hospital near Tunbridge Wells in 2012.

An undercover investigation carried out by ITV also exposed a litany of failings at the hospital group, including numerous suicide attempts and a teenager who spent weeks wearing only a blanket.

Read more: NHS to banish pagers from its hospitals — but is this a good idea?

Acadia bought The Priory Group for £1.3bn in 2016 from private equity firm Advent International. The motivation behind the sale is not clear, but the firm and its advisers have been making informal enquiries, according to sources.

Acadia Healthcare could not be reached for comment.

 

 

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • NHS
  • Private equity

Trending Articles

  • Why brands can fail miserably at sponsoring Wimbledon

  • Harry Styles at Wembley Stadium review: running through the grief

  • Ryanair warns of ‘passport queue chaos’ with new EU border system

  • World Cup boost fails to land UK services sector on front foot

  • UK fintech Starling to axe 130 roles in AI-powered simplification drive

More from City PM

  • Semble Secures £30M Series C Investment Led by Revaia to Expand Europe’s Connected Healthcare Platform

    Business Wire
  • Harley Street Health District Releases First Annual Impact Report

    Business Wire
  • Award winning Medtech firm excels again

    Partner
    Unable to generate alt text without specific article content or context. Please provide more details or context.
  • Boots eyes £7.5bn sale in blow to hopes of London IPO

    Retail
    Boots remains one of the group’s best performing business lines, with a London float suggested as recently as last year. (Photo by Oli Scarff/Getty Images)
  • AIRS Medical Welcomes Strategic Growth Investment from TA Associates to Accelerate Global Growth in AI-Powered MRI Solutions

    Business Wire
  • Medisca Enters Its Next Chapter Under Founder Antonio Dos Santos

    Business Wire
  • Coforge Wins Pega Industry Excellence Award for Government and Public Sector Transformation Work

    Business Wire
  • Johnson & Johnson Advances Cardiac Ablation Technology in Europe with Availability of Dual Energy THERMOCOOL SMARTTOUCH SF Platform

    Business Wire

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy